Imperial College London


Faculty of MedicineDepartment of Metabolism, Digestion and Reproduction

Honorary Research Associate



+44 (0)20 7594 2805r.gadaleta




140ICTEM buildingHammersmith Campus






Magnani L, Frige G, Gadaleta RM, et al., 2017, Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer, Nature Genetics, Vol:49, ISSN:1546-1718, Pages:444-450

Pellicciari R, Passeri D, De Franco F, et al., 2016, Discovery of 3 alpha,7 alpha,11 beta-Trihydroxy-6 alpha-ethyl-5 beta-cholan-24-oic Acid (TC-100), a Novel Bile Acid as Potent and Highly Selective FXR Agonist for Enterohepatic Disorders, Journal of Medicinal Chemistry, Vol:59, ISSN:0022-2623, Pages:9201-9214

Gadaleta RM, Cariello M, Sabba C, et al., 2015, Tissue-specific actions of FXR in metabolism and cancer, Biochimica Et Biophysica Acta-molecular and Cell Biology of Lipids, Vol:1851, ISSN:1388-1981, Pages:30-39

Gadaleta RM, Magnani L, 2014, Nuclear receptors and chromatin: an inducible couple, Journal of Molecular Endocrinology, Vol:52, ISSN:0952-5041, Pages:R137-R149

van Schaik FDM, Gadaleta RM, Schaap FG, et al., 2012, Pharmacological Activation of the Bile Acid Nuclear Farnesoid X Receptor Is Feasible in Patients with Quiescent Crohn's Colitis, Plos One, Vol:7, ISSN:1932-6203

More Publications